Finance

Lists
NUVB:NYSE
Nuvation Bio Inc
US$4,68
-0,85%
(-0,040) 1D
US$4,70
+0,42% (+0,020)
After hours
Closed: 14 ຕ.ລ., 16 ໂມງ 0 ນາທີ 10 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NUVB...
Open
US$4,66
High
US$4,80
Low
US$4,61
Mkt. cap
1,64 ຕື້
Avg. vol.
5,45 ລ້ານ
Volume
0,00
52-wk high
US$9,75
52-wk low
US$3,36
EPS
US$-0,44
Beta
1,61
Shares outstanding
351,12 ລ້ານ
No. of employees
305
Open
US$4,66
High
US$4,80
Low
US$4,61
Mkt. cap
1,64 ຕື້
Avg. vol.
5,45 ລ້ານ
Volume
0,00
52-wk high
US$9,75
52-wk low
US$3,36
EPS
US$-0,44
Beta
1,61
Shares outstanding
351,12 ລ້ານ
No. of employees
305
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
3 ມື້ກ່ອນ
3 Penny Stocks With Revenue Growth Over 1%
About Nuvation Bio Inc
CEODavid Hung
Employees305
Founded2018
Headquarters-
SectorPharmaceutical industry
Analyst ratings
Based on 9 analysts giving stock ratings to NUVB in the past 3 months
Strong buy
Buy
9
Hold
0
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for NUVB in the last 3 months.
Highest
Current US$4,68
US$21,00 (+348,72%)
Average
US$14,57 (+211,32%)
Lowest
US$11,00 (+135,04%)
Analyst
Recommendation
Action
Price target
Projected
Date
Leonid Timashev
RBC Capital
Buy
Maintained
US$20,00
+327,4%
10/12/2026
Geoff Meacham
Citi
Buy
Initiated
US$12,00
+156,4%
10/01/2026
Priyanka Grover
J.P. Morgan
Buy
Maintained
-
-
09/15/2026
David Nierengarten
Wedbush
Buy
Maintained
US$11,00
+135%
09/15/2026
Gregory Renza
Truist Financial
Buy
Maintained
-
-
09/15/2026
Li Watsek
Cantor Fitzgerald
Buy
Initiated
US$12,00
+156,4%
08/21/2026
Mayank Mamtani
B. Riley Securities
Buy
Maintained
US$14,00
+199,1%
08/07/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
US$21,00
+348,7%
08/07/2026
Boris Peaker
JonesTrading
Buy
Reiterated
US$12,00
+156,4%
08/06/2026
Yaron Werber
TD Cowen
Buy
Reiterated
-
-
06/01/2026
Soumit Roy
JonesTrading
Buy
Maintained
US$12,00
+156,4%
04/06/2026
Michael Yee
UBS
Hold
Maintained
US$7,00
+49,6%
03/03/2026
Last report
6 ສ.ຫ. 2026
Fiscal period
Q2 2026
US$-0,15 / US$-0,12
-25,15%miss
Revenue / Est. (USD)
31,69 ລ້ານ / 28,70 ລ້ານ
+10,42%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
13,12 ລ້ານ
41,86 ລ້ານ
83,23 ລ້ານ
31,69 ລ້ານ
Cost of goods sold
3,35 ລ້ານ
1,28 ລ້ານ
5,99 ລ້ານ
9,47 ລ້ານ
Cost of revenue
3,35 ລ້ານ
1,28 ລ້ານ
5,99 ລ້ານ
9,47 ລ້ານ
Research and development expenses
28,85 ລ້ານ
34,30 ລ້ານ
35,05 ລ້ານ
30,66 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
37,36 ລ້ານ
40,33 ລ້ານ
38,31 ລ້ານ
42,59 ລ້ານ
Operating expense
66,20 ລ້ານ
74,62 ລ້ານ
73,36 ລ້ານ
73,25 ລ້ານ
Total operating expenses
69,55 ລ້ານ
75,90 ລ້ານ
79,35 ລ້ານ
82,72 ລ້ານ
Operating income
-56,43 ລ້ານ
-34,04 ລ້ານ
3,88 ລ້ານ
-51,04 ລ້ານ
Other non operating income
1,14 ລ້ານ
-1,18 ລ້ານ
3,11 ລ້ານ
-179,00 ພັນ
EBT including unusual items
-55,79 ລ້ານ
-36,59 ລ້ານ
5,40 ລ້ານ
-62,84 ລ້ານ
EBT excluding unusual items
-55,80 ລ້ານ
-36,59 ລ້ານ
5,39 ລ້ານ
-53,38 ລ້ານ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-55,79 ລ້ານ
-36,59 ລ້ານ
5,40 ລ້ານ
-62,84 ລ້ານ
Net profit margin
-425,24%
-87,40%
6,48%
-198,31%
Earnings per share
-0,14
-0,09
0,04
-0,15
Interest and investment income
6,03 ລ້ານ
5,30 ລ້ານ
5,11 ລ້ານ
4,60 ລ້ານ
Interest expense
-6,53 ລ້ານ
-6,67 ລ້ານ
-6,71 ລ້ານ
-6,76 ລ້ານ
Net interest expenses
-501,00 ພັນ
-1,38 ລ້ານ
-1,60 ລ້ານ
-2,16 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
-55,90 ລ້ານ
-33,50 ລ້ານ
4,42 ລ້ານ
-50,50 ລ້ານ
Gain or loss from assets sale
-4,00 ພັນ
3,00 ພັນ
-
-1,00 ພັນ
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
ແອັບຂອງ Google